The agreement was signed with the group’s wholly-owned subsidiary, China Resources Pharmaceutical Commercial Group International Trading Co.
iX Biopharma has entered into an agreement with China Resources Pharmaceutical Commercial Group on Sept 30, for the licensing, supply and distribution of Wafesil in China.
Wafesil is a sublingual sildenafil wafer that treats male erectile dysfunction.
